Newcomb Jessica sold 2,400 shares of Tango Therapeutics, Inc. at $25.17 for −$60.4k on Sep 22, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Principal Accounting Officer
Principal Accounting Officer
Filed Sep 24, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$60,412.32Shares × reported price
Shares traded
2,400Common Stock
Price per share
$25.17Reported price. Read footnotes for ranges.
% of reported position traded
3.9%This security and ownership context
Holdings after
59,121Direct
Trade date
Sep 22, 2026Sell
Filed
Sep 24, 2026, 7:41 PM ET2-day reporting delay
Accession
0001193125-26-401327Code S · Transaction 229374
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 61,521 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 22, 2026Sell700$22.80−$15,962.03Trade 229372
Sep 22, 2026Sell5,100$23.97−$122,238.33Trade 229373
3 transaction rows in this filing. Joint filers share the same rows.

TNGX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TNGX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −3%1w ago −3%1d ago −9.3%
Returns since7d −0.7%30d −5.2%90d180d1y

Footnotes in full

F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 23, 2026. F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.37 to $23.32 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F3: The amount reported in Column 2 includes 43,666 unvested restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.52 to $24.41 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.59 to $25.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.